Rectum Carcinoma
7
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
57%
4 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic Irradiation
Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal Surgery
Induction and Consolidation Chemotherapy in Patients With Locally Advanced CRM-positive Rectal Cancer
Neoadjuvant Chemotherapy in Patients With Moderate Risk Mid Rectal Cancer
Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer
Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery
L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases